Abstract

In vitro, spheroid models have become well established in cancer research because they can better mimic certain characteristics of in vivo tumours. However, interaction with the tumour microenvironment, such as cancer-associated fibroblasts, plays a key role in tumour progression. We initially focused on the interaction of tumour cells with fibroblasts. To model this interaction, we developed a spheroid model of ovarian cancer and fibroblasts. To this end, ovarian cancer cell lines and ex vivo primary cells were simultaneously and sequentially seeded with fibroblasts in a scaffold-free system at different ratios and subsequently characterized with respect to changes in morphology, proliferation, and viability. We demonstrated that co-cultures are able to form by far more compact spheroids, especially in cells that form aggregates in mono-culture. In addition, the co-cultures were able to increase proliferation and sensitivity to cisplatin. Simultaneous seeding led fibroblasts invade the core in both cell lines and primary cells. These results show differences in formation, firmness, and size between co-culture and mono-culture. Our model is designed to better represent and characterize the mutual influencing factors of fibroblasts and tumour cells. Fibroblast-supplemented multicellular spheroids are a valuable tool for tumour microenvironment interaction and new drug discovery.

Details

Title
Multicellular ovarian cancer spheroids: novel 3D model to mimic tumour complexity
Author
Flörkemeier, Inken 1 ; Antons, Lisa K. 2 ; Weimer, Jörg P. 2 ; Hedemann, Nina 2 ; Rogmans, Christoph 2 ; Krüger, Sandra 3 ; Scherließ, Regina 4 ; Dempfle, Astrid 5 ; Arnold, Norbert 2 ; Maass, Nicolai 2 ; Bauerschlag, Dirk O. 6 

 University and University Medical Center Schleswig-Holstein Campus Kiel, Department of Gynaecology and Obstetrics, Kiel, Germany (GRID:grid.412468.d) (ISNI:0000 0004 0646 2097); Kiel University, KiNSIS Priority Research Area, Kiel, Germany (GRID:grid.9764.c) (ISNI:0000 0001 2153 9986) 
 University and University Medical Center Schleswig-Holstein Campus Kiel, Department of Gynaecology and Obstetrics, Kiel, Germany (GRID:grid.412468.d) (ISNI:0000 0004 0646 2097) 
 University and University Medical Center Schleswig-Holstein Campus Kiel, Department of Pathology, Kiel, Germany (GRID:grid.412468.d) (ISNI:0000 0004 0646 2097) 
 Kiel University, Department of Pharmaceutics and Biopharmaceutics, Kiel, Germany (GRID:grid.9764.c) (ISNI:0000 0001 2153 9986); Kiel University, KiNSIS Priority Research Area, Kiel, Germany (GRID:grid.9764.c) (ISNI:0000 0001 2153 9986) 
 University and University Medical Center Schleswig-Holstein Campus Kiel, Institute of Medical Informatics and Statistics, Kiel, Germany (GRID:grid.412468.d) (ISNI:0000 0004 0646 2097) 
 University and University Medical Center Schleswig-Holstein Campus Kiel, Department of Gynaecology and Obstetrics, Kiel, Germany (GRID:grid.412468.d) (ISNI:0000 0004 0646 2097); Jena University Hospital, Department of Gynaecology, Jena, Germany (GRID:grid.275559.9) (ISNI:0000 0000 8517 6224) 
Pages
23526
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3114644873
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.